CARDIO OSMOSIS
Integrated Solute–Water Kinetics • Transcellular Fluid Shifts • Cardiovascular & PK/PD Consultation Engine
BALANCED STATE — Sodium, water, and tonicity are within normal reference ranges.
Main Solute & Water Controls
140.0 mEq/L
<130130–134135–145 NORMAL146–150>150
Sodium is the primary extracellular cation determining effective plasma tonicity and driving fluid movements across cellular membranes.
42.00 L
TBW represents total body fluid. Altering TBW directly modifies solute concentration via dilution or concentration kinetics.
6725 mmol
Total exchangeable cations in osmotic equilibrium as defined by Edelman's relationship.
0 mmol
0 mL
100 mg/dL
Glucose is an effective osmole at elevated levels, pulling water from ICF to ECF (dilutional hyponatremia).
15.0 mg/dL
BUN increases measured osmolality but freely permeates cell membranes (ineffective osmole), creating no transcellular tonicity gradient.
Quantitative Osmotic Calculus
Active [Na+]
140.0
mEq/L
Measured Osmolality
290.9
mOsm/kg
Effective Tonicity
285.6
mOsm/kg
Edelman Equation: [Na+] = 1.03 × (Nae + Ke) / TBW − 25.1
Measured Osmolality = 2 × [Na+] + Glucose / 18 + BUN / 2.8
Effective Tonicity = 2 × [Na+] + Glucose / 18
Measured Osmolality = 2 × [Na+] + Glucose / 18 + BUN / 2.8
Effective Tonicity = 2 × [Na+] + Glucose / 18
∂Na / ∂TBW
−3.93
mEq/L per +1 L
Δ [Na+] per +1 mL H₂O
−0.0039
mEq/L
Δ [Na+] per +1 mmol Cation
+0.0245
mEq/L
Differential vs Exact Perturbation Analysis
🟢 BALANCED — NORMONATREMIA
🟢 NORMONATREMIA — BALANCED SODIUM–WATER STATE
NORMAL RANGE
Clinical status: Sodium (135–145 mEq/L) and effective tonicity are within normal reference ranges. Dynamic intracellular/extracellular distribution is balanced.
Therapeutic Reference: Maintenance fluid balance; no sodium-modifying interventions required.
🟡 HYPONATREMIA — DILUTIONAL / SOLUTE DEFICIT
LOW Na+
Clinical Management: Fluid restriction for SIADH or volume overload. Tolvaptan (V2 antagonist) indicated for hypervolemic/euvolemic hyponatremia. Hypertonic saline (3%) reserved for severe symptomatic presentations.
🔴 SEVERE HYPONATREMIA — ACUTE CEREBRAL EDEMA RISK
BRAIN SWELLING
Emergency Reference: Urgent 3% Hypertonic Saline bolus required to raise sodium by 4–6 mEq/L rapidly. Limit 24h correction to <8 mEq/L to prevent Osmotic Demyelination Syndrome (ODS).
🟠 HYPERNATREMIA — WATER DEFICIT / CONCENTRATION STATE
HIGH Na+
Treatment Reference: Free water replacement (hypotonic solutions such as D5W or 0.45% NaCl). Correct gradually (<10 mEq/L/day) to prevent cerebral edema.
🟡 HYPERVOLEMIA — EXTRACELLULAR FLUID OVERLOAD
FLUID OVERLOAD
Medicine Reference: Loop diuretics (e.g., Furosemide) to promote renal solute and water excretion, reducing intravascular expansion and cardiac preload.
🟡 HYPOVOLEMIA — VOLUME DEPLETION
LOW VOLUME
Treatment Reference: Isotonic crystalloids (0.9% NaCl or Balanced Sterofundin/Plasma-Lyte) to restore intravascular volume and organ perfusion.
Clinical Nomenclature Matrix
Low Sodium
Hyponatremia
<135 mEq/L
High Sodium
Hypernatremia
>145 mEq/L
Normal Sodium
Normonatremia
135–145 mEq/L
Fluid Excess
Hypervolemia
ECF Expansion
Fluid Deficit
Hypovolemia
ECF Depletion
Intracellular Swelling
Cerebral Edema
Hypotonic Water Shift
State Diagnostic Summary
CEREBRAL OSMOSIS CONSULTATION — Direct Specialist Advisory Channel
Brain Water Mechanics & Intracranial Dynamics
Transcellular hypotonic fluid shifts induce rapid neuronal swelling, raising intracranial pressure (ICP), while hypertonic dehydration triggers cell desiccation and vascular shear stress.
Physiologic Model: Vcell / V0 = (Tonicity0 / Tonicitycurrent)0.55
Consult on Cerebral Osmosis Parameters
Transfer live patient tonicity, sodium, and estimated brain volume calculations directly to Ejiro Inije for advanced clinical evaluation.
Clinical Neurological Evaluation
Primary Risk Indicators:
• Acute Hypotonicity (<120 mEq/L): Severe risk of cerebral edema, uncal herniation, and seizures.
• Hypertonic Desiccation (>155 mEq/L): Risk of neuronal shrinkage, subdural traction, and intracranial hemorrhage.
• Acute Hypotonicity (<120 mEq/L): Severe risk of cerebral edema, uncal herniation, and seizures.
• Hypertonic Desiccation (>155 mEq/L): Risk of neuronal shrinkage, subdural traction, and intracranial hemorrhage.
CARDIOVASCULAR HEMODYNAMICS — Dedicated Regimen Consultation
Integrated Hemodynamic Modeling
Extracellular volume expansion directly modulates venous return, myocardial preload, cardiac output, and mean arterial pressure (MAP).
ECF = TBW − ICF | Preload Scale = ECF / 14.0
MAP = CVP + (CO × SVR / 80)
MAP = CVP + (CO × SVR / 80)
Cardiovascular & Preload Consultation
Discuss volume-coupled hemodynamic responses, Frank-Starling curve adjustments, and cardiac workload management.
Volume & Hemodynamic Indicators
Hemodynamic Thresholds:
• ECF Overload (>16.5 L): Elevated ventricular filling pressures, risk of acute pulmonary edema.
• ECF Depletion (<11.5 L): Decreased cardiac output, reflex tachycardia, organ hypoperfusion.
• ECF Overload (>16.5 L): Elevated ventricular filling pressures, risk of acute pulmonary edema.
• ECF Depletion (<11.5 L): Decreased cardiac output, reflex tachycardia, organ hypoperfusion.
PHARMACOKINETIC & PHARMACODYNAMIC CONSULTATION
Osmotic & Diuretic Pharmacology
Review clinical PK profiles including Mannitol IV, Furosemide, Tolvaptan, and 3% Hypertonic Saline.
PK/PD Dosing & Clearance Review
Consult on multi-compartment drug clearance, half-life parameters, and therapeutic regimens tailored to live sodium/water states.
Pharmacological Reference
Therapeutic Regimen Reference:
• Tolvaptan: V2 receptor antagonist for dilutional hyponatremia aquaresis.
• Mannitol IV: Rapid extracellular expansion and cerebral osmotic de-swelling.
• 3% NaCl: Controlled correction of acute severe hyponatremia.
• Tolvaptan: V2 receptor antagonist for dilutional hyponatremia aquaresis.
• Mannitol IV: Rapid extracellular expansion and cerebral osmotic de-swelling.
• 3% NaCl: Controlled correction of acute severe hyponatremia.
MATHEMATICAL MODELING & CALCULUS VERIFICATION
Differential Calculus Verification
Evaluate first-order partial derivatives (∂Na/∂TBW and ∂Na/∂N) against exact Edelman non-linear predictions.
∂Na / ∂TBW = −1.03 × (Nae + Ke) / TBW²
∂Na / ∂N = 1.03 / TBW
∂Na / ∂N = 1.03 / TBW
Mathematical Modeling Consultation
Consult directly with industrial mathematician Ejiro Inije on differential equation formulations, state-space modeling, and calculus verification.
Solute-Water Calculus Overview
Calculus Summary:
Validates exact perturbation dynamics using partial derivatives to quantify instant changes in serum sodium per milliliter of water or millimole of exchangeable cation shift.
Validates exact perturbation dynamics using partial derivatives to quantify instant changes in serum sodium per milliliter of water or millimole of exchangeable cation shift.